Congenital histiocytosis with central nervous system involvement and a novel PTPRJ::RASGRF1 fusion

  • Paul G. Kemps*
  • , Marianna Bugiani
  • , Marijn A. Scheijde-Vermeulen
  • , Marco J. Koudijs
  • , Jean François Emile
  • , Olvert A. Berkhemer
  • , Wes Onland
  • , Cor van den Bos
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Histiocytic neoplasms are rare diseases characterized by clonal expansions of cells with a macrophage or dendritic cell phenotype. They are driven by mutations activating the MAPK pathway and may involve diverse organs, including the central nervous system (CNS). We describe a newborn with congenital histiocytosis affecting the CNS, skin, lungs, lymph nodes, thyroid, fingernail, and soft tissues – including a tumor originating from the tongue obstructing the upper airway. Histopathology revealed an atypical histiocytosis with strong CD1a and variable Langerin expression; post-mortem transcriptome sequencing identified a novel PTPRJ::RASGRF1 fusion. This case expands the molecular landscape of histiocytic neoplasms, highlighting the value of comprehensive genomic profiling.

Original languageEnglish
Article number100492
JournalEJC Paediatric Oncology
Volume7
Early online date13 Feb 2026
DOIs
Publication statusE-pub ahead of print - 13 Feb 2026

Keywords

  • Brain
  • CNS
  • ERK
  • Histiocytic neoplasm
  • Indeterminate dendritic cell histiocytosis
  • Langerhans cell histiocytosis
  • MAPK

Fingerprint

Dive into the research topics of 'Congenital histiocytosis with central nervous system involvement and a novel PTPRJ::RASGRF1 fusion'. Together they form a unique fingerprint.

Cite this